World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: Netherlands Trial Register
Last refreshed on: 28 April 2013
Main ID:  NTR508
Date of registration: 15/09/2005
Primary sponsor: University Hospital Maastricht (AZM), Department of Surgery
Public title: Introduction of a breast cancer care programme in ultra short stay (ambulatory/24 stay setting) in 4 early adopter centres: implementation and evaluation.
Scientific title: Introduction of a breast cancer care programme in ultra short stay (ambulatory/24 stay setting) in 4 early adopter centres: implementation and evaluation. - MADO
Date of first enrolment: 1/12/2004
Target sample size: 400
Recruitment status: complete
URL:  http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=508
Study type:  intervention
Study design:  Randomised: No; Masking: None; Control: Not applicable; Group: [default]; Type: Single arm  
Countries of recruitment
The Netherlands
Contacts
Name: M.F.  Meyenfeldt
Address:  University Hospital Maastricht, Departement of Surgery, P.O. Box 5800 , P. Debeylaan 25 6202 AZ Maastricht The Netherlands
Telephone: +31 (0)43 3877478
Email: mf.vonmeyenfeldt@ah.unimaas.nl
Affiliation: 
Name: M.F.  Meyenfeldt
Address:  University Hospital Maastricht, Departement of Surgery, P.O. Box 5800 , P. Debeylaan 25 6202 AZ Maastricht The Netherlands
Telephone: +31 (0)43 3877478
Email: mf.vonmeyenfeldt@ah.unimaas.nl
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: Breast cancer patients of all ages undergoing all types of surgical interventions for breast cancer.
Exclusion criteria: Contraindications are those related to the physiology of the patient, and therefore not age or any of the surgery types employed in the treatment of breast cancer.

Age minimum:
Age maximum:
Gender:
Health Condition(s) or Problem(s) studied
Breast cancer

Intervention(s)
A comprehensive care programme for breast cancer surgery in ultra short stay; in 4 early adopter hospitals.
Primary Outcome(s)
Percent patients in ultra short stay,
- percent patients treated according to protocol,
- cost-effectiveness of the care programme and implementation programme.
Secondary Outcome(s)
1. Patient satisfaction;

2. Degree of involvement of home care nursing);


Process indicators:

a. access time to out patient department,

b. time spent in the diagnostic process,

c. access time to the surgical procedure,

d. surgical quality of care (complications, nr of re-operations),

e. patient satisfaction.
Secondary ID(s)
945-14-411
ISRCTN77253391
Source(s) of Monetary Support
ZON-MW, The Netherlands Organization for Health Research and Development
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history